Skip to main content
. 2021 Mar;23(3):358–371. doi: 10.1016/j.jmoldx.2020.12.003

Figure 3.

Figure 3

The somatic mutational signature components for tumor samples T5, T9A, T9B, T10, and T13 indicated by the signature number, suggested etiology, and the percentage contribution to the overall mutational composition for each sample. APOBEC, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like.